Development and Clinical Application of a Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for SARS-CoV-2 Infection

Author:

Hu Xuejiao1,Deng Qianyun1,Li Junmin2,Chen Jierong1,Wang Zixia1,Zhang Xiqin1,Fang Zhixin3,Li Haijian3,Zhao Yunhu1,Yu Pan4,Li Wenmin1,Wang Xiaoming2,Li Shan2,Zhang Lei2ORCID,Hou Tieying1ORCID

Affiliation:

1. Division of Laboratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People’s Republic of China

2. MOE International Joint Lab for Synthetic Biology and Medicine, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, People’s Republic of China

3. Department of Laboratory Medicine and Central Laboratories, Guangdong Second Provincial General Hospital, Guangzhou, People’s Republic of China

4. Genskey Biotechnology Co. Ltd., Beijing, People’s Republic of China

Abstract

We developed a visual and rapid reverse transcription–loop-mediated isothermal amplification (RT-LAMP) assay targeting the S gene for SARS-CoV-2 infection. The strength of our study was that we validated the RT-LAMP assay using 481 clinical respiratory samples from two prospective cohorts of suspected COVID-19 patients and on the serial samples from an asymptomatic carrier. The developed RT-LAMP approach showed an increased sensitivity (88.89%) and high consistency (kappa, 0.92) compared with those of reverse transcription-quantitative PCR (RT-qPCR) for SARS-CoV-2 screening while requiring only constant-temperature heating and visual inspection, facilitating SARS-CoV-2 screening in well-equipped labs as well as in the field. The time required for RT-LAMP was less than 1 h from sample preparation to the result (more than 2 h for RT-qPCR). This study showed that the RT-LAMP assay was a simple, rapid, and sensitive approach for SARS-CoV-2 infection and can facilitate COVID-19 diagnosis, especially in resource-poor settings.

Funder

Peak Project Scientific Research Special Funding

Guangdong Medical Research Foundation

Guangdong Science and Technology Department

Publisher

American Society for Microbiology

Subject

Molecular Biology,Microbiology

Reference32 articles.

1. World Health Organization. 2020. Coronavirus disease 2019 (COVID-19) situation report-198. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200805-covid-19-sitrep-198.pdf?sfvrsn=f99d1754_2. Accessed 5 August 2020.

2. National Health Commission of the People’s Republic of China. 2020. Diagnosis and treatment of novel coronavirus pneumonia (trial version six). http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml. (In Chinese.) Accessed 3 March 2020.

3. World Health Organization. 2020. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf. Accessed 13 March 2020.

4. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

5. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3